Genetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations

PLoS Genetics

Volumn 9, Issue 4, 2013, Pages

  Hill, Jessica A ^a   Ammar, Ron ^a   Torti, Dax ^b   Nislow, Corey ^a   Cowen, Leah E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CYCLOSPORIN A; FLUCONAZOLE; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; MICONAZOLE; RADICICOL; TACROLIMUS;

ANEUPLOIDY; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGAL GENETICS; FUNGAL GENOME; GENE; GENE MUTATION; GENE SEQUENCE; LCB1 GENE; MINIMUM INHIBITORY CONCENTRATION; MOT3 GENE; NONHUMAN; PDR1 GENE; SACCHAROMYCES CEREVISIAE;

ANEUPLOIDY; ANTIFUNGAL AGENTS; AZOLES; BENZOQUINONES; CALCINEURIN; CANDIDA ALBICANS; DNA-BINDING PROTEINS; DRUG COMBINATIONS; DRUG RESISTANCE, FUNGAL; ERGOSTEROL; EVOLUTION, MOLECULAR; HSP90 HEAT-SHOCK PROTEINS; LACTAMS, MACROCYCLIC; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TACROLIMUS; TRANSCRIPTION FACTORS;

CANDIDA ALBICANS; SACCHAROMYCES CEREVISIAE;

EID: 84876834080     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003390     Document Type: Article

References (106)

1. Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, et al. (2011) Tackling antibiotic resistance. Nat Rev Microbiol 9: 894-896.
2. Chopra I, (2012) The 2012 Garrod Lecture: Discovery of antibacterial drugs in the 21st century. J Antimicrob Chemother 68 (3):: 496-505 doi:10.1093/jac/dks436.
3. Palumbi SR, (2001) Humans as the world's greatest evolutionary force. Science 293: 1786-1790.
4. Shapiro RS, Robbins N, Cowen LE, (2011) Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev 75: 213-267.
5. Cowen LE, (2008) The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype. Nat Rev Microbiol 6: 187-198.
6. Brown GD, Denning DW, Levitz SM, (2012) Tackling human fungal infections. Science 336: 647.
7. Pfaller MA, Diekema DJ, (2010) Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 36: 1-53.
8. Torella JP, Chait R, Kishony R, (2010) Optimal drug synergy in antimicrobial treatments. PLoS Comput Biol 6: e1000796 doi:10.1371/journal.pcbi.1000796.
9. zur Wiesch PA, Kouyos R, Engelstadter J, Regoes RR, Bonhoeffer S, (2011) Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infect Dis 11: 236-247.
10. Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, et al. (1998) Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 279: 450-454.
11. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338: 853-860.
12. Nakagawa F, Lodwick RK, Smith CJ, Smith R, Cambiano V, et al. (2012) Projected life expectancy of people with HIV according to timing of diagnosis. AIDS 26: 335-343.
13. WHO (2011) World Malaria Report 2011. World Health Organization. Geneva, Switzerland: WHO Press. 79 p. Available: http://www.who.int/malaria/world_malaria_report_2011/en/.
14. WHO (2012) Global Tuberculosis Report 2012. World Health Organization. Geneva, Switzerland: WHO Press. 91 p. Available: http://www.who.int/tb/publications/global_report/en/.
15. Steinbach WJ, Reedy JL, Cramer RA Jr, Perfect JR, Heitman J, (2007) Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol 5: 418-430.
16. Cowen LE, Lindquist S, (2005) Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 309: 2185-2189.
17. Taipale M, Jarosz DF, Lindquist S, (2010) HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 11: 515-528.
18. Cruz MC, Goldstein AL, Blankenship JR, Del Poeta M, Davis D, et al. (2002) Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J 21: 546-559.
19. Imai J, Yahara I, (2000) Role of HSP90 in salt stress tolerance via stabilization and regulation of calcineurin. Mol Cell Biol 20: 9262-9270.
20. Cowen LE, Carpenter AE, Matangkasombut O, Fink GR, Lindquist S, (2006) Genetic architecture of Hsp90-dependent drug resistance. Eukaryot Cell 5: 2184-2188.
21. Singh SD, Robbins N, Zaas AK, Schell WA, Perfect JR, et al. (2009) Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog 5: e1000532 doi:10.1371/journal.ppat.1000532.
22. Cowen LE, Singh SD, Kohler JR, Collins C, Zaas AK, et al. (2009) Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci U S A 106: 2818-2823.
23. Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, et al. (2011) Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog 7: e1002257 doi:10.1371/journal.ppat.1002257.
24. Uppuluri P, Nett J, Heitman J, Andes D, (2008) Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother 52: 1127-1132.
25. Sanglard D, (2002) Resistance of human fungal pathogens to antifungal drugs. Curr Opin Microbiol 5: 379-385.
26. Anderson JB, (2005) Evolution of antifungal-drug resistance: mechanisms and pathogen fitness. Nat Rev Microbiol 3: 547-556.
27. White TC, Marr KA, Bowden RA, (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11: 382-402.
28. Balzi E, Wang M, Leterme S, Van Dyck L, Goffeau A, (1994) PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J Biol Chem 269: 2206-2214.
29. Favre B, Didmon M, Ryder NS, (1999) Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans. Microbiology 145 (Pt 10):: 2715-2725.
30. Anderson JB, Sirjusingh C, Parsons AB, Boone C, Wickens C, et al. (2003) Mode of selection and experimental evolution of antifungal drug resistance in Saccharomyces cerevisiae. Genetics 163: 1287-1298.
31. Marchetti O, Moreillon P, Glauser MP, Bille J, Sanglard D, (2000) Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob Agents Chemother 44: 2373-2381.
32. Pfaller MA, Diekema DJ, (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
33. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, et al. (2009) Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 48: 1695-1703.
34. Marr KA, (2010) Fungal infections in oncology patients: update on epidemiology, prevention, and treatment. Curr Opin Oncol 22: 138-142.
35. Pfaller MA, (2012) Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 125: S3-13.
36. Berman J, Sudbery PE, (2002) Candida albicans: a molecular revolution built on lessons from budding yeast. Nat Rev Genet 3: 918-930.
37. Cowen LE, Steinbach WJ, (2008) Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance. Eukaryot Cell 7: 747-764.
38. Onyewu C, Blankenship JR, Del Poeta M, Heitman J, (2003) Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei. Antimicrob Agents Chemother 47: 956-964.
39. Hemenway CS, Heitman J, (1999) Calcineurin. Structure, function, and inhibition. Cell Biochem Biophys 30: 115-151.
40. Etzkorn FA, Chang ZY, Stolz LA, Walsh CT, (1994) Cyclophilin residues that affect noncompetitive inhibition of the protein serine phosphatase activity of calcineurin by the cyclophilin.cyclosporin A complex. Biochemistry 33: 2380-2388.
41. Kissinger CR, Parge HE, Knighton DR, Lewis CT, Pelletier LA, et al. (1995) Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 378: 641-644.
42. Schulte TW, Akinaga S, Soga S, Sullivan W, Stensgard B, et al. (1998) Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin. Cell Stress Chaperones 3: 100-108.
43. Stebbins CE, Russo AA, Schneider C, Rosen N, Hartl FU, et al. (1997) Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell 89: 239-250.
44. Borkovich KA, Farrelly FW, Finkelstein DB, Taulien J, Lindquist S, (1989) Hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperatures. Mol Cell Biol 9: 3919-3930.
45. Minami Y, Kimura Y, Kawasaki H, Suzuki K, Yahara I, (1994) The carboxy-terminal region of mammalian HSP90 is required for its dimerization and function in vivo. Mol Cell Biol 14: 1459-1464.
46. Cyert MS, Kunisawa R, Kaim D, Thorner J, (1991) Yeast has homologs (CNA1 and CNA2 gene products) of mammalian calcineurin, a calmodulin-regulated phosphoprotein phosphatase. Proc Natl Acad Sci U S A 88: 7376-7380.
47. Hongay C, Jia N, Bard M, Winston F, (2002) Mot3 is a transcriptional repressor of ergosterol biosynthetic genes and is required for normal vacuolar function in Saccharomyces cerevisiae. EMBO J 21: 4114-4124.
48. Kolaczkowska A, Goffeau A, (1999) Regulation of pleiotropic drug resistance in yeast. Drug Resist Updat 2: 403-414.
49. Hendrych T, Kodedova M, Sigler K, Gaskova D, (2009) Characterization of the kinetics and mechanisms of inhibition of drugs interacting with the S. cerevisiae multidrug resistance pumps Pdr5p and Snq2p. Biochim Biophys Acta 1788: 717-723.
50. Cowen LE, Sanglard D, Calabrese D, Sirjusingh C, Anderson JB, et al. (2000) Evolution of drug resistance in experimental populations of Candida albicans. J Bacteriol 182: 1515-1522.
51. Sanglard D, Ischer F, Marchetti O, Entenza J, Bille J, (2003) Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol 48: 959-976.
52. Buede R, Rinker-Schaffer C, Pinto WJ, Lester RL, Dickson RC, (1991) Cloning and characterization of LCB1, a Saccharomyces gene required for biosynthesis of the long-chain base component of sphingolipids. J Bacteriol 173: 4325-4332.
53. Dickson RC, Lester RL, (2002) Sphingolipid functions in Saccharomyces cerevisiae. Biochim Biophys Acta 1583: 13-25.
54. Spitzer M, Griffiths E, Blakely KM, Wildenhain J, Ejim L, et al. (2011) Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole. Mol Syst Biol 7: 499.
55. Chen JK, Lane WS, Schreiber SL, (1999) The identification of myriocin-binding proteins. Chem Biol 6: 221-235.
56. Anderson JB, Funt J, Thompson DA, Prabhu S, Socha A, et al. (2010) Determinants of divergent adaptation and Dobzhansky-Muller interaction in experimental yeast populations. Curr Biol 20: 1383-1388.
57. Dettman JR, Rodrigue N, Melnyk AH, Wong A, Bailey SF, et al. (2012) Evolutionary insight from whole-genome sequencing of experimentally evolved microbes. Mol Ecol 21: 2058-2077.
58. Blazquez J, (2003) Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin Infect Dis 37: 1201-1209.
59. Selmecki AM, Dulmage K, Cowen LE, Anderson JB, Berman J, (2009) Acquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistance. PLoS Genet 5: e1000705 doi:10.1371/journal.pgen.1000705.
60. White TC, (1997) Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41: 1482-1487.
61. Chen B, Zhong D, Monteiro A, (2006) Comparative genomics and evolution of the HSP90 family of genes across all kingdoms of organisms. BMC Genomics 7: 156.
62. Neckers L, Workman P, (2012) Hsp90 molecular chaperone inhibitors: are we there yet? Clin Cancer Res 18: 64-76.
63. Trepel J, Mollapour M, Giaccone G, Neckers L, (2010) Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 10: 537-549.
64. Whitesell L, Lindquist SL, (2005) HSP90 and the chaperoning of cancer. Nat Rev Cancer 5: 761-772.
65. Millson SH, Prodromou C, Piper PW, (2010) A simple yeast-based system for analyzing inhibitor resistance in the human cancer drug targets Hsp90alpha/beta. Biochem Pharmacol 79: 1581-1588.
66. Prodromou C, Nuttall JM, Millson SH, Roe SM, Sim TS, et al. (2009) Structural basis of the radicicol resistance displayed by a fungal hsp90. ACS Chem Biol 4: 289-297.
67. Ericson E, Hoon S, St Onge RP, Giaever G, Nislow C, (2010) Exploring gene function and drug action using chemogenomic dosage assays. Methods Enzymol 470: 233-255.
68. Heitman J, Movva NR, Hiestand PC, Hall MN, (1991) FK 506-binding protein proline rotamase is a target for the immunosuppressive agent FK 506 in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 88: 1948-1952.
69. Cardenas ME, Muir RS, Breuder T, Heitman J, (1995) Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A. EMBO J 14: 2772-2783.
70. Gaali S, Gopalakrishnan R, Wang Y, Kozany C, Hausch F, (2011) The chemical biology of immunophilin ligands. Curr Med Chem 18: 5355-5379.
71. Paya CV, (1993) Fungal infections in solid-organ transplantation. Clin Infect Dis 16: 677-688.
72. Blankenship JR, Singh N, Alexander BD, Heitman J, (2005) Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens. J Clin Microbiol 43: 464-467.
73. Reedy JL, Husain S, Ison M, Pruett TL, Singh N, et al. (2006) Immunotherapy with tacrolimus (FK506) does not select for resistance to calcineurin inhibitors in Candida albicans isolates from liver transplant patients. Antimicrob Agents Chemother 50: 1573-1577.
74. LaFayette SL, Collins C, Zaas AK, Schell WA, Betancourt-Quiroz M, et al. (2010) PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90. PLoS Pathog 6: e1001069 doi:10.1371/journal.ppat.1001069.
75. Alberti S, Halfmann R, King O, Kapila A, Lindquist S, (2009) A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137: 146-158.
76. Anderson JB, Ricker N, Sirjusingh C, (2006) Antagonism between two mechanisms of antifungal drug resistance. Eukaryot Cell 5: 1243-1251.
77. Selmecki A, Forche A, Berman J, (2006) Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 313: 367-370.
78. Selmecki A, Gerami-Nejad M, Paulson C, Forche A, Berman J, (2008) An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1. Mol Microbiol 68: 624-641.
79. Sasse C, Dunkel N, Schafer T, Schneider S, Dierolf F, et al. (2012) The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans. Mol Microbiol 86: 539-556.
80. Cowen LE, Kohn LM, Anderson JB, (2001) Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans. J Bacteriol 183: 2971-2978.
81. Selmecki A, Forche A, Berman J, (2010) Genomic plasticity of the human fungal pathogen Candida albicans. Eukaryot Cell 9: 991-1008.
82. Dolgin E, Motluk A, (2011) Heat shock and awe. Nat Med 17: 646-649.
83. Luo W, Sun W, Taldone T, Rodina A, Chiosis G, (2010) Heat shock protein 90 in neurodegenerative diseases. Mol Neurodegener 5: 24.
84. Yeh PJ, Hegreness MJ, Aiden AP, Kishony R, (2009) Drug interactions and the evolution of antibiotic resistance. Nat Rev Microbiol 7: 460-466.
85. Chait R, Craney A, Kishony R, (2007) Antibiotic interactions that select against resistance. Nature 446: 668-671.
86. Hegreness M, Shoresh N, Damian D, Hartl D, Kishony R, (2008) Accelerated evolution of resistance in multidrug environments. Proc Natl Acad Sci U S A 105: 13977-13981.
87. Michel JB, Yeh PJ, Chait R, Moellering RC Jr, Kishony R, (2008) Drug interactions modulate the potential for evolution of resistance. Proc Natl Acad Sci U S A 105: 14918-14923.
88. Wahl LM, Gerrish PJ, (2001) The probability that beneficial mutations are lost in populations with periodic bottlenecks. Evolution 55: 2606-2610.
89. Smith AM, Heisler LE, St Onge RP, Farias-Hesson E, Wallace IM, et al. (2010) Highly-multiplexed barcode sequencing: an efficient method for parallel analysis of pooled samples. Nucleic acids research 38: e142.
90. Engel SR, Balakrishnan R, Binkley G, Christie KR, Costanzo MC, et al. (2010) Saccharomyces Genome Database provides mutant phenotype data. Nucleic acids research 38: D433-436.
91. Skrzypek MS, Arnaud MB, Costanzo MC, Inglis DO, Shah P, et al. (2010) New tools at the Candida Genome Database: biochemical pathways and full-text literature search. Nucleic acids research 38: D428-432.
92. Jones T, Federspiel NA, Chibana H, Dungan J, Kalman S, et al. (2004) The diploid genome sequence of Candida albicans. Proceedings of the National Academy of Sciences of the United States of America 101: 7329-7334.
93. van het Hoog M, Rast TJ, Martchenko M, Grindle S, Dignard D, et al. (2007) Assembly of the Candida albicans genome into sixteen supercontigs aligned on the eight chromosomes. Genome biology 8: R52.
94. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome biology 10: R25.
95. Li H, Ruan J, Durbin R, (2008) Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome research 18: 1851-1858.
96. Li R, Li Y, Kristiansen K, Wang J, (2008) SOAP: short oligonucleotide alignment program. Bioinformatics 24: 713-714.
97. Li H, Durbin R, (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
98. Langmead B, Salzberg SL, (2012) Fast gapped-read alignment with Bowtie 2. Nat Methods 9: 357-359.
99. Li H, Homer N, (2010) A survey of sequence alignment algorithms for next-generation sequencing. Brief Bioinform 11: 473-483.
100. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
101. Fiume M, Williams V, Brook A, Brudno M, (2010) Savant: genome browser for high-throughput sequencing data. Bioinformatics 26: 1938-1944.
102. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, et al. (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome research 20: 1297-1303.
103. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, et al. (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491-498.
104. Roth A, Ding J, Morin R, Crisan A, Ha G, et al. (2012) JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data. Bioinformatics 28: 907-913.
105. Liti G, Carter DM, Moses AM, Warringer J, Parts L, et al. (2009) Population genomics of domestic and wild yeasts. Nature 458: 337-341.
106. Xie C, Tammi MT, (2009) CNV-seq, a new method to detect copy number variation using high-throughput sequencing. BMC bioinformatics 10: 80.